Terms: = Breast cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin
155 results:
1. Phytochemical Profiling by UHPLC-Q-TOF/MS and Chemopreventive Effect of Aqueous Extract of
Rojas-Armas JP; Palomino-Pacheco M; Arroyo-Acevedo JL; Ortiz-Sánchez JM; Justil-Guerrero HJ; Martínez-Heredia JT; Castro-Luna A; Rodríguez Flores C; Guzmán Duxtan AJ
Molecules; 2024 Mar; 29(6):. PubMed ID: 38543016
[No Abstract] [Full Text] [Related]
2. Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report.
Yang Y; Lee J; Woo CG; Lee OJ; Son SM
Diagn Pathol; 2024 Jan; 19(1):16. PubMed ID: 38243242
[TBL] [Abstract] [Full Text] [Related]
3. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
4. Reprogramming tumor-associated macrophages to outcompete endovascular endothelial progenitor cells and suppress tumor neoangiogenesis.
Do MH; Shi W; Ji L; Ladewig E; Zhang X; Srivastava RM; Capistrano KJ; Edwards C; Malik I; Nixon BG; Stamatiades EG; Liu M; Li S; Li P; Chou C; Xu K; Hsu TW; Wang X; Chan TA; Leslie CS; Li MO
Immunity; 2023 Nov; 56(11):2555-2569.e5. PubMed ID: 37967531
[TBL] [Abstract] [Full Text] [Related]
5. Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed.
Ghosh P; K M M; Pandey N; Basavan D
Anticancer Drugs; 2023 Nov; 34(10):1085-1093. PubMed ID: 37823283
[TBL] [Abstract] [Full Text] [Related]
6. The direct medical cost of breast cancer management in a provincial hospital of Papua New Guinea: A cost of illness study of consecutive patients from 2017 to 2022.
Umo I; Kulai M; Umo P; James K; Ikasa R
J Cancer Policy; 2023 Dec; 38():100447. PubMed ID: 37813161
[TBL] [Abstract] [Full Text] [Related]
7.
Cho CY; Kang SH; Kim BC; Kim TK; Kim JH; Kim M; Sohn Y; Jung HS
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594079
[TBL] [Abstract] [Full Text] [Related]
8. Machine learning model for anti-cancer drug combinations: Analysis, prediction, and validation.
Zhou JB; Tang D; He L; Lin S; Lei JH; Sun H; Xu X; Deng CX
Pharmacol Res; 2023 Aug; 194():106830. PubMed ID: 37343647
[TBL] [Abstract] [Full Text] [Related]
9. Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer.
Wang Y; Luo Y; Fu S; He L; Pan G; Fan D; Wen Q; Fan Y
Front Endocrinol (Lausanne); 2023; 14():1095604. PubMed ID: 37223020
[TBL] [Abstract] [Full Text] [Related]
10. Clinically Translatable Transcrocetin Delivery Platform for Correction of Tumor Hypoxia and Enhancement of Radiation Therapy Effects.
Diringer MC; Coliat P; Mathieu C; Laurent N; Mura C; Banerjee M; Zhu C; Grabowska A; Ritchie A; Clarke P; Bernard A; Vit C; Burckel H; Noel G; Harvey P; Pivot X; Detappe A
Small; 2023 Mar; 19(12):e2205961. PubMed ID: 36587987
[TBL] [Abstract] [Full Text] [Related]
11. Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the tsc1/mTOR signaling pathway.
Wang W; Zhang Z; Zhao M; Wang Y; Ge Y; Shan L
J Biol Chem; 2023 Jan; 299(1):102812. PubMed ID: 36539038
[TBL] [Abstract] [Full Text] [Related]
12. Fish Oil and Selenium with Doxorubicin Modulates Expression of Fatty Acid Receptors and Selenoproteins, and Targets Multiple Anti-cancer Signaling in Triple-negative breast cancer Tumors.
Guo CH; Shih MY; Chung CH; Lin YC; Fan CT; Peng CL; Chen PC; Hsia S
Int J Med Sci; 2022; 19(14):2044-2057. PubMed ID: 36483592
[TBL] [Abstract] [Full Text] [Related]
13. Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
Caliskan S; Akar OS; Gun S; Kefeli M
Turk Patoloji Derg; 2023; 39(3):212-217. PubMed ID: 36367123
[TBL] [Abstract] [Full Text] [Related]
14. AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors.
Dunn S; Eberlein C; Yu J; Gris-Oliver A; Ong SH; Yelland U; Cureton N; Staniszewska A; McEwen R; Fox M; Pilling J; Hopcroft P; Coker EA; Jaaks P; Garnett MJ; Isherwood B; Serra V; Davies BR; Barry ST; Lynch JT; Yusa K
Oncogene; 2022 Nov; 41(46):5046-5060. PubMed ID: 36241868
[TBL] [Abstract] [Full Text] [Related]
15. Lipid-Associated Macrophages Are Induced by cancer-Associated Fibroblasts and Mediate Immune Suppression in breast cancer.
Timperi E; Gueguen P; Molgora M; Magagna I; Kieffer Y; Lopez-Lastra S; Sirven P; Baudrin LG; Baulande S; Nicolas A; Champenois G; Meseure D; Vincent-Salomon A; Tardivon A; Laas E; Soumelis V; Colonna M; Mechta-Grigoriou F; Amigorena S; Romano E
Cancer Res; 2022 Sep; 82(18):3291-3306. PubMed ID: 35862581
[TBL] [Abstract] [Full Text] [Related]
16. Documenting patients' and providers' preferences when proposing a randomized controlled trial: a qualitative exploration.
Oberoi D; Kwok C; Li Y; Railton C; Horsman S; Reynolds K; Joy AA; King KM; Lupichuk SM; Speca M; Culos-Reed N; Carlson LE; Giese-Davis J
BMC Med Res Methodol; 2022 Mar; 22(1):64. PubMed ID: 35249528
[TBL] [Abstract] [Full Text] [Related]
17. Mechanistic Target of Rapamycin (mTOR) Inhibitors.
Wang D; Eisen HJ
Handb Exp Pharmacol; 2022; 272():53-72. PubMed ID: 35091825
[TBL] [Abstract] [Full Text] [Related]
18. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Herranz C; Mateo F; Baiges A; Ruiz de Garibay G; Junza A; Johnson SR; Miller S; García N; Capellades J; Gómez A; Vidal A; Palomero L; Espín R; Extremera AI; Blommaert E; Revilla-López E; Saez B; Gómez-Ollés S; Ancochea J; Valenzuela C; Alonso T; Ussetti P; Laporta R; Xaubet A; Rodríguez-Portal JA; Montes-Worboys A; Machahua C; Bordas J; Menendez JA; Cruzado JM; Guiteras R; Bontoux C; La Motta C; Noguera-Castells A; Mancino M; Lastra E; Rigo-Bonnin R; Perales JC; Viñals F; Lahiguera A; Zhang X; Cuadras D; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Filippakis H; Hakem R; Gorrini C; Ferrer M; Ugun-Klusek A; Billett E; Radzikowska E; Casanova Á; Molina-Molina M; Roman A; Yanes O; Pujana MA
EMBO Mol Med; 2021 Sep; 13(9):e13929. PubMed ID: 34378323
[TBL] [Abstract] [Full Text] [Related]
19. Heterogeneity and cancer-Related Features in Lymphangioleiomyomatosis Cells and Tissue.
Espín R; Baiges A; Blommaert E; Herranz C; Roman A; Saez B; Ancochea J; Valenzuela C; Ussetti P; Laporta R; Rodríguez-Portal JA; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Villar-Piqué A; Diaz-Lucena D; Llorens F; Casanova Á; Molina-Molina M; Plass M; Mateo F; Moss J; Pujana MA
Mol Cancer Res; 2021 Nov; 19(11):1840-1853. PubMed ID: 34312290
[TBL] [Abstract] [Full Text] [Related]
20. Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA).
Sauter M; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen A; Kingswood JC;
Orphanet J Rare Dis; 2021 Jul; 16(1):301. PubMed ID: 34229737
[TBL] [Abstract] [Full Text] [Related]
[Next]
